It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

Les membres du public assistant à la réunion dans un lieu de téléconférence auront la possibilité de formuler des commentaires publics à chaque endroit, avec les mêmes limitations que celles imposées ...

Bmp 信号传导已被证明可以调节胰腺发育的早期方面，但其在内分泌（尤其是 β 细胞）分化中的作用仍不清楚。利用斑马鱼胚胎细胞自主调节单细胞中 Bmp 信号传导的能力，我们研究了 Bmp 信号 ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

El Instituto de Medicina Regenerativa de California y su Comité de Supervisión de Ciudadanos Independientes, y sus subcomités, cumplen con la Ley de Estadounidenses con Discapacidades (ADA, por sus ...

政府对生产移植到患者体内的细胞有严格的规定。例如，这些法规禁止使用可能向人类传播疾病的动物产品。在这种背景下，管理其他基于细胞的疗法（例如骨髓移植）的高质量和严格监管的 ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

干细胞具有恢复因损伤或疾病而受损的组织的独特潜力。 过去几年干细胞研究的迅速扩展表明，有一些研究发现可以用于临床转化研究。 CIRM 早期转化 II 研究奖 RFA 的目的是支持能够实现这一 ...